- $36.58bn
- $40.42bn
- $10.40bn
Brief: Broadwood Partners Comments On STAAR Surgical Board Dissent On Revised Sale To Alcon
Brief: Yunqi Capital Comments On Staar Surgical’S Go-Shop Process And Alcon’S Revised Offer
BNP picks medtech favourites, sees re-rating in H2 2026
Swiss stocks - Factors to watch on December 10
Deals of the day-Mergers and acquisitions
Brief: Broadwood Partners Continues To Urge STAAR Shareholders To Vote “Against” Proposed Transaction with Alcon
Deals of the day-Mergers and acquisitions
Alcon lifts bid for medical technology firm Staar to $1.6 billion (updated)
STAAR Surgical climbs after Alcon announces amended merger deal
Brief: Alcon Announces Amended Merger Agreement With Staar Surgical
Alcon's outlook confirmation soothes some investor nerves, shares jump
Alcon jumps premarket after confirmed outlook, Q3 EPS beat
Swiss stocks - Factors to watch on November 12
Swiss stocks - Factors to watch on November 11
Staar Surgical falls; co opens 30-day go-shop, postpones vote on Alcon deal
Brief: Staar Surgical Announces Amendments To Alcon Merger Agreement
Brief: Alcon Releases Investor Discussion Materials of Merger Proposal for STAAR Stockholders
Brief: Alcon Releases Investor Discussion Materials Reinforcing Certain Value Of Merger Proposal For Staar Stockholders
Brief: Alcon And Staar Surgical Announce Adjournment Of Staar Special Meeting Of Stockholders